Trials / Completed
CompletedNCT04949828
Effect of CREON on Exocrine Pancreatic Insufficiency (EPI) Symptoms
Observational Study Assessing for Effect of CREON on Symptoms of Exocrine Pancreatic Insufficiency (EPI) in Patients With EPI Due to Chronic Pancreatitis (CP)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 63 (actual)
- Sponsor
- AbbVie · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Exocrine Pancreatic Insufficiency (EPI) is a condition where pancreatic enzyme quantity or activity is reduced below threshold needed for normal digestion. Symptoms include bloating, flatulence, diarrhea and steatorrhea. This is an observational study assessing for effect of CREON on symptoms of EPI in participants with EPI due to chronic pancreatitis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | CREON | Oral Capsules |
Timeline
- Start date
- 2021-09-16
- Primary completion
- 2024-02-29
- Completion
- 2024-02-29
- First posted
- 2021-07-02
- Last updated
- 2024-03-28
Locations
6 sites across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT04949828. Inclusion in this directory is not an endorsement.